Gut microbiome analysis as a predictive marker for the gastric cancer patients

Yangyang Zhang,Jian Shen,Xinwei Shi,Yaoqiang Du,Yaofang Niu,Gulei Jin,Zhen Wang,Jianxin Lyu
DOI: https://doi.org/10.1007/s00253-020-11043-7
IF: 5
2021-01-01
Applied Microbiology and Biotechnology
Abstract:Gut microbiota have been implicated in the development of cancer. Colorectal and gastric cancers, the major gastrointestinal tract cancers, are closely connected with the gut microbiome. Nevertheless, the characteristics of gut microbiota composition that correlate with gastric cancer are unclear. In this study, we investigated gut microbiota alterations during the progression of gastric cancer to identify the most relevant taxa associated with gastric cancer and evaluated the potential of the microbiome as an indicator for the diagnosis of gastric cancer. Compared with the healthy group, gut microbiota composition and diversity shifted in patients with gastric cancer. Different bacteria were used to design a random forest model, which provided an area under the curve value of 0.91. Verification samples achieved a true positive rate of 0.83 in gastric cancer. Principal component analysis showed that gastritis shares some microbiome characteristics of gastric cancer. Chemotherapy reduced the elevated bacteria levels in gastric cancer by more than half. More importantly, we found that the genera <i>Lactobacillus</i> and <i>Megasphaera</i> were associated with gastric cancer.
biotechnology & applied microbiology
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to explore the characteristics of the gut microbiome in gastric cancer patients and evaluate its potential as a diagnostic marker for gastric cancer. Specifically, the researchers focused on the following aspects: 1. **Differences in the gut microbiome between gastric cancer patients and healthy individuals**: The study revealed significant differences between gastric cancer patients (GC) and healthy control groups (H) by comparing the composition of their gut microbiomes. These differences are reflected not only in the changes of bacterial species, but also in the changes of microbial diversity. 2. **Establishment of a random forest model for distinguishing gastric cancer patients**: Based on the discovered microbiome differences, the researchers constructed a random forest model to distinguish gastric cancer patients from healthy individuals. The results showed that the model had a high accuracy (the AUC value was 0.91), and the true positive rate of the validation samples was 0.83. 3. **Similarity of the microbiome between gastritis patients and gastric cancer patients**: The study also explored the microbiome characteristics between gastritis patients (Gas) and gastric cancer patients, and found that gastritis patients shared some microbiome characteristics with gastric cancer patients in some aspects, but not completely. This indicates that gastritis may be an early stage of gastric cancer. 4. **The effect of chemotherapy on the gut microbiome of gastric cancer patients**: The study analyzed the changes in the gut microbiome of gastric cancer patients before and after chemotherapy, and found that chemotherapy significantly reduced the abundance and diversity of microorganisms, especially those bacterial species that were increased in gastric cancer. 5. **Identification of predictive markers for gastric cancer**: By comparing the microbiomes of gastric cancer patients with those of other groups (healthy individuals, gastritis patients, colorectal cancer patients), the study finally identified two bacterial genera - Lactobacillus and Megasphaera - which can be used as predictive markers for gastric cancer. ### Key Conclusions - There are significant differences in the gut microbiome between gastric cancer patients and healthy individuals, and these differences can be used to diagnose gastric cancer with high sensitivity and specificity. - Gastritis patients and gastric cancer patients have some overlapping microbiome characteristics, but not completely, suggesting that gastritis may be an early stage of gastric cancer. - Chemotherapy significantly reduces the abundance and diversity of gut microorganisms in gastric cancer patients, especially those bacterial species that are increased in gastric cancer. - Lactobacillus and Megasphaera can be used as predictive markers for gastric cancer. These findings provide new non - invasive tools for the early diagnosis of gastric cancer and important clues for further research on the pathogenesis and treatment strategies of gastric cancer.